
The newly created Chair in Thoracic Oncology is in honor of thoracic oncologist Thierry Jahan, M.D.

A benefit for Lung Cancer Research and to celebrate the Addario Lung Cancer Medical Institute.
A gift to the Thoracic Oncology Progam helps us discover new treatments and cures for lung cancer, esophageal cancer and mesothelioma.
Interview with U.S. News and World Report
Read article
Sarita Dubey, M.D. is a medical oncologist who has dedicated her career to the treatment of thoracic malignancies. Dr. Dubey earned her medical degree from Kilpauk Medical College in Madras, India. She then completed a residency in internal medicine at Hennepin County Medical Center and a clinical oncology fellowship at the University of Wisconsin, Madison. At UW, she trained under Dr. Joan Schiller, a world-renowned thoracic oncologist. Following her clinical fellowship, she completed two years of rigorous training in lung cancer research methodology through the UW Academic Oncologist Training Program, part of a prestigious NCI (National Cancer Institute) K12 grant. Dr. Dubey later served as Study Chair on several clinical trials testing novel therapies for non-small cell lung cancer.
Dr. Dubey was recruited to UCSF and joined the faculty there in 2005. The Thoracic Oncology Program then selected her to chair the clinical trials site committee with a mandate to expand the program. In addition to her local leadership at UCSF, Dr. Dubey is a core member of the respiratory committee of CALGB, Cancer and Leukemia Group B, a national clinical research group sponsored by the NCI, and a principal investigator on several CALGB trials. Dr. Dubey's long-term goal is to offer a clinical trial at UCSF for every type and stage of lung cancer and to also address the clinical research needs for less common malignancies such as mesothelioma.
Dr. Dubey has published numerous peer-reviewed articles in the field and regularly presents her work to professional audiences. She is a member of many professional organizations including the American Medical Association (AMA), American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (IASLC) and the National Lung Cancer Partnership.